Mivapharm SRL
Mivapharm reported total assets of €1.23m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Mivapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets +19 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mivapharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 12 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Mivapharm's financial analysis
- Solvency50.6%sector median: 20.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mivapharm
Mivapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0473.651.691
- VAT number
- BE0473651691
- Peppol
- Registered · 0208:0473651691 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2000
- Registered office
- 4431 Ans
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Mivapharm (SRL) has been based in Ans since 2000, active in: buying and selling of own real estate. For 2025, it reports a net profit of 86,667 € and equity of 621,589 €; its revenue is not published. Its solvency stands at 50.6%, above the median of its sector (20.0%).
Companies similar to Mivapharm
Companies in the same business, of comparable size and area, outside its group.
- DL2 Invest Business and other management consultancy activities Wanze · balance sheet €1.28m
- EDEN Business and other management consultancy activities Sint-Genesius-Rode · balance sheet €1.79m
- G 4 G - Invest Activities of holding companies Zonhoven · balance sheet €2.07m
- Societe DU LIS Activities of holding companies Brussels · balance sheet 729,410 €
- DER Consult Business and other management consultancy activities Mouscron · balance sheet €2.24m
- Mission Business and other management consultancy activities Izegem · balance sheet €2.65m
- VBGL Business and other management consultancy activities Lasne · balance sheet 577,215 €
- ACN Buying and selling of own real estate Ixelles · balance sheet 977,071 €
Frequently asked questions about Mivapharm
What is the revenue of Mivapharm?
Mivapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mivapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0473651691 for Mivapharm, if the company is VAT-registered. Its company number (CBE) is 0473.651.691.
Where is the registered office of Mivapharm?
According to the CBE register, the registered office of Mivapharm is in 4431 Ans.
What is the equity of Mivapharm?
At the close of the 2025 financial year, the equity of Mivapharm amounts to 621,589 €, a solvency of 50.6% of total assets.
Who manages Mivapharm?
The register lists 2 active mandates at Mivapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mivapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →